Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

VR and mozart take on high blood pressure in the ER

NCT ID NCT07272486

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding virtual reality (VR) and classical music to standard blood pressure medication can help people who come to the emergency room with very high blood pressure (hypertensive urgency). 130 adults with high blood pressure but no organ damage were randomly assigned to get either standard treatment alone or standard treatment plus VR and music. Researchers measured blood pressure and anxiety levels over two hours to see if the non-drug approach made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

130 people

The number who actually took part.

Started

Aug 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Clinical diagnosis of primary hypertension * Presentation to the emergency department with hypertensive urgency * Absence of any signs of acute end-organ damage * Ability to understand the study and provide informed consent * Able to cooperate with serial blood pressure measurements Exclusion Criteria: * Age younger than 18 years * Diagnosis of secondary hypertension * Any medication intolerance or known hypersensitivity to captopril or nitrate therapy * Current severe psychiatric disorder or cognitive impairment interfering with participation * Contraindications to using virtual reality (history of severe vertigo, epilepsy, motion sickness, etc.) * Hemodynamic instability requiring immediate high-intensity medical intervention * Pregnancy or breastfeeding * Inability or unwillingness to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertensive urgency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergencies essential hypertension Hypertensive Crisis hypertensive urgency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Ankara, Çankaya, 06170, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.